论文部分内容阅读
目的:探讨我院住院患儿多重耐药菌的分布情况及药物治疗情况。方法:通过目标性监测,收集我院2015年多重耐药菌感染病例资料,对多重耐药菌的分布及治疗情况进行统计分析。结果:我院2015年来共检出多重耐药菌378株,多重耐药菌检出率8.32%,主要为耐甲氧西林金黄色葡萄球菌(38.62%)、大肠埃希菌(26.46%)、肺炎克雷伯菌(14.81%)、阴沟杆菌阴沟亚科(12.17%)、耐碳青霉烯类鲍曼不动杆菌(4.50%)、多耐药铜绿假单胞菌(0.79%)。送检的标本主要为痰液、脓液、血液、中段尿,检出的病例多为社区感染,主要集中在重症监护室。结论:我院对多重耐药菌的管理有一定的成效,仍需继续加强控制措施。
Objective: To investigate the distribution of multidrug-resistant bacteria in hospitalized children and drug treatment in our hospital. Methods: Through targeted surveillance, we collected data on multi-drug resistant bacterial infections in our hospital in 2015, and analyzed the distribution and treatment of multi-drug resistant bacteria. Results: A total of 378 multidrug-resistant bacteria were detected in our hospital in 2015, with the detection rate of multidrug-resistant bacteria being 8.32%, including methicillin-resistant Staphylococcus aureus (38.62%), Escherichia coli (26.46%), Klebsiella pneumoniae (14.81%), Enterobacter cloacae subfamily (12.17%), Carbapenem resistant Acinetobacter baumannii (4.50%), and multidrug resistant Pseudomonas aeruginosa (0.79%). The specimens were mainly for sputum, pus, blood, urine in the middle, most of the detected cases were community-based infections, mainly in intensive care unit. Conclusion: Our hospital has certain effect on the management of multidrug-resistant bacteria, and we still need to continue to strengthen the control measures.